Balistreri, Giuseppe

Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., van der Meer, F., Kallio, K., Kaya, T., Anastasina, M., et al. (2020) · Science

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 1,925

SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity

Martínez-Mármol, R., Giordano-Santini, R., Kaulich, E., Cho, A.-N., Przybyla, M., Riyadh, M. A., Robinson, E., Chew, K. Y., Amor, R., Meunier, F. A., et al. (2023) · Science Advances

SARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19

Cited by 94

UNC-45a promotes myosin folding and stress fiber assembly

Lehtimäki, J. I., Fenix, A. M., Kotila, T. M., Balistreri, G., Paavolainen, L., Varjosalo, M., Burnette, D. T., & Lappalainen, P. (2017) · Journal of Cell Biology

Cellular Mechanics and InteractionsHeat shock proteins research

Cited by 47

Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG‐Syt1‐SV2 plasma membrane nanocluster for synaptic vesicle entry

Joensuu, M., Syed, P., Saber, S. H., Lanoue, V., Wallis, T. P., Rae, J., Blum, A., Gormal, R. S., Small, C., Sanders, S., et al. (2023) · The EMBO Journal

Botulinum Toxin and Related Neurological DisordersCellular transport and secretion

Cited by 34

Synaptotagmin 1 mediates toxicity of botulinum neurotoxin type A

Joensuu, M., Lanoue, V., Syed, P., Wallis, T. P., Rae, J., Blum, A., Gormal, R., Small, C., Sanders, S., Jiang, A., et al. (2022) · The EMBO Journal

Botulinum Toxin and Related Neurological DisordersCellular transport and secretion

Cited by 34